Pharma groups question enhanced approach in Q14, call for more alignment between Q14 and Q2(R2)
Regulatory NewsJoanne S. Eglovitch
Chemistry, Manufacturing and Controls (CMC)GlobalPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/PolicyResearch, Design and Development